Swiss Life Sciences Stock News

Roche Holding (SWX:ROG) has drawn fresh investor attention after the FDA accepted its supplemental Biologics License Application for Gazyva/Gazyvaro in systemic lupus erythematosus and the company expanded its oncology research collaboration with C4 Therapeutics. See our latest analysis for Roche Holding. The recent FDA sBLA acceptance for Gazyva/Gazyvaro in systemic lupus erythematosus and the new degrader antibody collaboration with C4 Therapeutics come after a mixed stretch for the shares,...

Wondering whether Lonza Group at around CHF 508 per share offers value, or if the price still looks rich? This article walks through the numbers so you can judge that for yourself. The stock has had a mixed run, with a 4.8% decline over the last week, an 8.7% gain over the last 30 days, and a 1-year return of an 8.9% decline, which may signal shifting views on both risk and opportunity. Recent coverage has focused on Lonza Group's position in the life sciences sector and how investors are...

VAT Group (SWX:VACN) reaffirmed its 2026 outlook after issuing second quarter sales guidance of CHF 265 million to CHF 295 million, even as first quarter 2026 sales of CHF 221 million showed a year on year decline. See our latest analysis for VAT Group. VAT Group's share price has climbed 13.27% over the past 30 days and 35.78% year to date, while the 1 year total shareholder return of 111.39% points to strong momentum following the reaffirmed 2026 outlook and AI driven semiconductor demand...

Peach Property Group (SWX:PEAN) has just reported first half FY 2025 revenue of €69.975 million with a basic EPS loss of €0.26, setting a cautious tone around profitability at a share price of €5.90. The business has seen revenue move from €69.041 million in the first half of 2024 to €73.379 million in the second half of 2024 and then to €69.975 million in the latest period. Basic EPS losses widened from €1.05 in the first half of 2024 to €4.11 in the second half before moderating to €0.26,...

Avolta (SWX:AVOL) is back on investors’ radars after recent share price swings, with the stock posting a 4.5% decline over the past week but a small gain over the past month. See our latest analysis for Avolta. Zooming out, Avolta’s recent 7 day share price return of negative 6.4% and 1 day drop of 4.5% come after a 1 year total shareholder return of 31.9%. This suggests momentum has cooled but longer term holders are still ahead. If you are weighing Avolta’s swings against other...

In the first quarter ended March 31, 2026, Temenos AG reported revenue of US$252.96 million and net income of US$39.74 million, both higher than a year earlier, alongside increased basic and diluted earnings per share from continuing operations. This improvement in profitability, combined with the recently completed CHF100 million repurchase of 1,377,899 shares, highlights Temenos’s focus on both operational and capital efficiency. Next, we’ll examine how Temenos’s higher first-quarter...

Wondering whether Nestlé at around CHF 75.36 is starting to look like value or still pricing in a premium? This article breaks down what the recent market signals might be telling you. The stock has recently seen a 5.1% decline over the last week, with a 0.7% decline over 30 days and a 1.4% decline year to date, and it is 9.5% lower over 1 year, 27.4% lower over 3 years, and 18.6% lower over 5 years. Recent coverage has focused on how this weaker share price record is shaping investor...

LHH, part of Adecco Group (SWX:ADEN), has released new research on redeployment programs during a period of widespread layoffs. The study finds a major perception gap between HR leaders, who report that redeployment options exist, and employees, many of whom are unaware of these programs. The research links this disconnect to workforce changes driven by AI adoption and evolving market demands. Adecco Group, through its LHH brand, is closely tied to how companies manage talent through...

Dividend increase as a fresh signal for EPIC Suisse EPIC Suisse (SWX:EPIC) recently received shareholder approval at its 10 April 2026 AGM for a higher dividend of CHF 3.20 per share for the 2025 business year, payable on 21 April 2026. This decision places income returns at the center of the story for this Swiss real estate owner and manager. It also gives investors a fresh reference point for weighing the stock’s recent price performance and income profile. See our latest analysis for EPIC...

With the business potentially at an important milestone, we thought we'd take a closer look at Peach Property Group...

Amrize (SWX:AMRZ) has caught investor attention after a recent price move, with the share closing at CHF 46.0. This development puts the focus on how its building solutions business is currently positioned. See our latest analysis for Amrize. The recent CHF 46.0 share price sits against a 1 month share price return of 9.9% and a 3 month share price return of 9.5%. This suggests short term momentum has picked up, while year to date gains remain more modest at 3.4%. If this move has you...

Comet Holding (SWX:COTN) has drawn attention after reporting first quarter 2026 net sales of CHF 106.3 million, a 4.5% year on year decline, while reaffirming guidance that full year net sales should significantly exceed 2025. See our latest analysis for Comet Holding. The share price has moved sharply higher in recent weeks, with a 30.1% year to date share price return and a 53.7% total shareholder return over the past year. This suggests momentum has been building as investors react to the...

Helvetia Baloise Holding AG recently reported full-year 2025 results, with net income of CHF 552.3 million and basic earnings per share of CHF 10.32, and also approved an annual dividend of CHF 7.70 per share payable on May 29, 2026. The combination of higher earnings and an increased cash return through the dividend offers fresh insight into how Helvetia Baloise is allocating capital between shareholder payouts and ongoing growth initiatives. We’ll now examine how the stronger full-year...

As European markets experience a positive momentum, with the STOXX Europe 600 Index rising by 1.91% amid favorable corporate earnings and geopolitical developments, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In such an environment, finding undervalued stocks involves assessing companies with strong fundamentals that may have been overlooked or mispriced by the market, offering potential opportunities for long-term growth despite...

ABB recently secured a contract to supply gearless mill drive and ring-geared mill drive systems for the Eva Copper Mine Project in Queensland, Australia, aiming to boost grinding efficiency, reliability and operational flexibility for the copper concentrator. This mining technology win highlights ABB’s role in enabling the energy transition through critical-minerals projects that increasingly demand efficient, low-risk processing solutions. We’ll now examine how winning a major copper mine...

Barry Callebaut (SWX:BARN) has come back into focus after forming a Growth Accelerator Coalition and outlining a tighter set of priorities, along with tactical reinvestments following earlier operational disruptions that weighed on volumes. See our latest analysis for Barry Callebaut. That renewed focus comes after a sharp reset in sentiment, with a 7 day share price return of an 18.36% decline and a 30 day share price return of a 19.75% decline. Even though the 1 year total shareholder...

Chocoladefabriken Lindt & Sprüngli (SWX:LISN) has launched its Lindt EXCELLENCE Fusion line, a layered dark and milk or white chocolate bar aimed at widening appeal among consumers who find pure dark chocolate too intense. See our latest analysis for Chocoladefabriken Lindt & Sprüngli. At a share price of CHF107,000.0, the 1 day share price return of 1.90% comes after a weaker patch, with a 90 day share price return showing a 6.63% decline and a 1 year total shareholder return showing a 7.04%...

UBS Group (SWX:UBSG) is in focus after Chairman Colm Kelleher warned that proposed Swiss capital rules could leave the bank as an international outlier and force difficult choices about future business priorities. See our latest analysis for UBS Group. The share price has moved up to CHF34.45, with a 1 month share price return of 15.14% and a 7 day gain of 5.29%. However, the 90 day share price return is a 9.39% decline and the year to date share price return is a 9.75% decline. At the same...

Implenia (SWX:IMPN) has secured a contract exceeding €200 million to plan and build the new Münster police headquarters in Germany, a long-dated project with completion targeted for October 2029. See our latest analysis for Implenia. The contract news arrives after a mixed period for the stock, with the share price at CHF66.8 and a year-to-date share price return showing a decline of 15.44%, but a 1-year total shareholder return of 56.24%, suggesting that long-term momentum remains stronger...

If you are wondering whether Alcon's current share price still reflects good value or if the market has already priced in the story, this article walks through the key numbers so you can judge that for yourself. Alcon shares last closed at US$63.90, with returns of 3.7% over the past week, 6.7% over the last 30 days and 0.6% year to date, while the 1 year return stands at a 14.9% decline. Recent headlines around Alcon have focused on its position in eye care and medical equipment, along with...

Last week, SHL Telemedicine Ltd. ( VTX:SHLTN ) insiders, who had purchased shares in the previous 12 months were...

Novartis (SWX:NOVN) CEO Vas Narasimhan has joined the board of AI company Anthropic, marking the first time a major pharmaceutical chief executive has taken a board role at a leading artificial intelligence startup. Novartis is expanding global health and community outreach programs, targeting improved cancer and cardiovascular disease outcomes in over 30 countries by 2030. The company is also advancing late-stage therapies for myasthenia gravis, adding another area of focus to its...

Helvetia Baloise Holding (SWX:HBAN) has drawn fresh attention after reporting full year 2025 earnings and confirming an annual dividend of CHF 7.70 per share, scheduled for payment on May 29, 2026. See our latest analysis for Helvetia Baloise Holding. The 11.09% 30 day share price return, together with a 27.50% 1 year total shareholder return and a latest share price of CHF 222.40, indicates that momentum has been building around the recent earnings and dividend announcement. If these...

AI driven beauty launch puts Givaudan (SWX:GIVN) in focus Givaudan Active Beauty’s partnership with Haut.AI to showcase AI powered ingredient simulations at in cosmetics Global 2026 is drawing fresh attention to how the business connects scientific claims with consumer facing experiences. See our latest analysis for Givaudan. At a share price of CHF2,964.0, Givaudan has seen short term momentum pick up, with a 1 month share price return of 6.66% and 7 day gain of 5.56%. However, the 1 year...